High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study - Top-Institutions - MDSpire

High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study

  • By

  • Liv Tybjærg Nordestgaard

  • Jiao Luo

  • Frida Emanuelsson

  • Genevieve Leyden

  • Eleanor Sanderson

  • George Davey Smith

  • Mette Christoffersen

  • Shoaib Afzal

  • Marianne Benn

  • Børge G Nordestgaard

  • Anne Tybjærg-Hansen

  • Ruth Frikke-Schmidt

  • January 22, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, England

    Key Differentiators

    • Neurology
    • Genetic Epidemiology
    • Cardiovascular Medicine

  • #2

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Epidemiology
    • Metabolic Medicine

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Neurology
    • Genetics
    • Public Health

  • #4

    University College London (UCL)
    University College London (UCL)

    London, England

    Key Differentiators

    • Neurology
    • Genetic Epidemiology
    • Cardiovascular Research

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Neurology
    • Epidemiology
    • Cardiovascular Medicine

Original Source(s)

High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study

  • by Liv Tybjærg Nordestgaard, Jiao Luo, Frida Emanuelsson, Genevieve Leyden, Eleanor Sanderson, George Davey Smith, Mette Christoffersen, Shoaib Afzal, Marianne Benn, Børge G Nordestgaard, Anne Tybjærg-Hansen, Ruth Frikke-Schmidt

  • January 22, 2026

Related Content

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

Pasteurized Akkermansia muciniphila alleviates high-fat diet-induced bone loss via Nr4a1-dependent Treg differentiation